| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.27 | 1e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 1e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.25 | 5e-06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |